organophosphonates has been researched along with prostaglandin d2 in 6 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (prostaglandin d2) | Trials (prostaglandin d2) | Recent Studies (post-2010) (prostaglandin d2) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 3,454 | 78 | 751 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brassard, CL; Federici, ME; Seiler, S | 1 |
| Hamid-Bloomfield, S; Whittle, BJ | 1 |
| Andersen, NH; Hanson, SR; Harker, LA; Tynan, SS; Wills, MT | 1 |
| Herschman, HR; Reddy, ST | 1 |
| Akiba, S; Kitatani, K; Sato, T | 1 |
| Authier, H; Auwerx, J; Balard, P; Benoit-Vical, F; Berry, A; Chambon, P; Coste, A; Desvergne, B; Lagane, C; Lepert, JC; Magnaval, JF; Metzger, D; Olagnier, D; Pipy, B; Séguéla, JP; Wahli, W | 1 |
6 other study(ies) available for organophosphonates and prostaglandin d2
| Article | Year |
|---|---|
SQ-27986 inhibition of platelet aggregation is mediated through activation of platelet prostaglandin D2 receptors.
Topics: Adenosine Diphosphate; Adenylyl Cyclases; Blood Platelets; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Membrane; Cyclic AMP; Enzyme Activation; Fatty Acids, Unsaturated; Humans; Molecular Structure; Organophosphonates; Organophosphorus Compounds; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin D2; Protein Kinases; Receptors, Immunologic; Receptors, Prostaglandin | 1990 |
Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Animals; Blood Platelets; Guinea Pigs; Male; Organophosphonates; Organophosphorus Compounds; Platelet Aggregation; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Prostaglandins D; Prostanoic Acids; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides | 1986 |
On the multiplicity of platelet prostaglandin receptors. II. The use of N-0164 for distinguishing the loci of action for PGI2, PGD2, PGE2 and hydantoin analogs.
Topics: Blood Platelets; Dinoprostone; Epoprostenol; Humans; Hydantoins; Organophosphonates; Organophosphorus Compounds; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandin D2; Prostaglandins; Prostaglandins D; Prostaglandins E; Receptors, Cell Surface; Receptors, Prostaglandin; Structure-Activity Relationship | 1984 |
Prostaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells.
Topics: Animals; Antibodies, Monoclonal; Arachidonic Acids; Isoenzymes; Mast Cells; Mice; Organophosphonates; Phospholipases; Phospholipases A; Phospholipases A2; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Receptors, IgE; Sulfonamides | 1997 |
Role of phospholipase D-derived phosphatidic acid as a substrate for phospholipase A2 in RBL-2H3 cells.
Topics: Animals; Antigens; Arachidonic Acids; Cytosol; Dinitrophenols; Enzyme Activation; Enzyme Inhibitors; Leukemia, Basophilic, Acute; Organophosphonates; Phosphatidic Acids; Phospholipase D; Phospholipases A; Phospholipases A2; Prostaglandin D2; Rats; Serum Albumin, Bovine; Tumor Cells, Cultured | 2000 |
IL-13 induces expression of CD36 in human monocytes through PPARgamma activation.
Topics: Anilides; Animals; Arachidonic Acids; CD36 Antigens; Cell Line, Tumor; DNA; Enzyme Inhibitors; Erythrocytes; Gene Expression; Humans; Hypoglycemic Agents; Interleukin-13; Macrophages; Macrophages, Peritoneal; Mice; Monocytes; Organophosphonates; Phagocytosis; Phospholipases A; Phospholipases A2; Plasmodium falciparum; PPAR gamma; Prostaglandin D2; Protein Binding; Rosiglitazone; Thiazolidinediones; Transfection | 2007 |